East Africa’s healthcare landscape is undergoing a digital revolution, yet access to essential medicines remains a challenge for millions. MyDawa, a Nairobi-based healthtech startup, is positioning itself as a key player in bridging this gap after securing $9.6 million (~KES 1.3 billion) in new funding round led by global investors, including private equity firms Alta Semper and Creadev, alongside Denmark’s Investment Fund for Developing Countries (IFU), Japan’s AAIC Investment, and Ohara Pharmaceutical Co, the company said in a statement to Launch Base Africa.
The investment will drive MyDawa’s expansion across East Africa, enhance its AI-powered platform, and bolster chronic disease management programs. The deal highlights rising confidence in Africa’s digital health sector, where startups are increasingly filling gaps left by underfunded public health systems.
A Model Built for Scale
Founded in 2017 by Neil O’Leary, MyDawa operates an integrated “bricks-and-clicks” model, combining e-pharmacy services with physical distribution networks. Patients can consult doctors online, order lab tests, receive e-prescriptions, and have medications delivered — a critical service in regions where pharmacies are scarce or inconsistent in stock.
The company’s recent acquisition of Uganda’s Rocket Health, a telehealth provider, has already extended its reach in the country. Now, with fresh capital, MyDawa plans deeper regional penetration and tech upgrades to streamline inventory management and reduce costs.
“This investment confirms that MyDawa is not just solving real problems at scale — it’s building a blueprint for the future of healthcare in Africa,” O’Leary said.
The backing of Alta Semper, Creadev , AAIC and others — all known for healthcare and consumer investments in emerging markets — signals a vote of confidence in MyDawa’s sustainable growth. The startup reported over 30% year-on-year revenue growth in 2024, serving 1.8 million patients across Kenya and Uganda.
“We’ve witnessed MyDawa’s ability to deliver transformative healthcare solutions at scale,” said Zach Fond, Partner at Alta Semper. “This next phase reinforces its position as a category leader.”
The company’s chronic-care programs, such as Kenya’s Mzima and Uganda’s Bulunji, cater to patients with long-term conditions like diabetes and hypertension. Additionally, partnerships with pharmaceutical giants like Novo Nordisk and initiatives funded by the Gates Foundation — including HIV prevention programs — have expanded its impact.
Despite its growth, MyDawa faces hurdles. Regulatory complexities vary across East African markets, and competition is intensifying, with rivals like Nigeria’s HealthPlus and South Africa’s Dis-Chem also vying for dominance in Africa’s e-pharmacy space.
Yet MyDawa’s hybrid model — combining digital convenience with physical logistics — gives it an edge. Priscilla Muhiu, the company’s COO, says the funding will accelerate its vision of a “digitally empowered, accessible healthcare ecosystem for every East African.”
As Africa’s healthtech sector matures, MyDawa’s success could set a benchmark for how digital innovation can democratize healthcare in underserved regions — if it can navigate the challenges ahead.